Ekso Bionics Holdings Inc.

5.71-0.7700-11.88%Vol 387.78K1Y Perf 68.05%
Apr 15th, 2021 16:00 DELAYED
BID5.68 ASK5.75
Open6.40 Previous Close6.48
Pre-Market- After-Market-
 - -%  - -
Target Price
10.00 
Analyst Rating
Strong Buy 1.00
Potential %
75.13 
Finscreener Ranking
★+     45.08
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
+     38.55
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★+     39.65
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap71.95M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
23.89 
Earnings Date
29th Apr 2021

Today's Price Range

5.676.40

52W Range

2.8014.98

5 Year PE Ratio Range

-1.90-3.80

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-12.42%
1 Month
-22.52%
3 Months
-30.20%
6 Months
22.01%
1 Year
68.05%
3 Years
-76.93%
5 Years
-94.56%
10 Years
-

TickerPriceChg.Chg.%
EKSO5.71-0.7700-11.88
AAPL134.502.47001.87
GOOG2 296.6641.82001.85
MSFT259.503.91001.53
XOM56.98-0.3400-0.59
WFC42.240.25000.60
JNJ160.390.47000.29
FB307.825.00001.65
GE13.55-0.1300-0.95
JPM152.170.96000.63
Financial StrengthValueIndustryS&P 500US Markets
3.30
3.70
0.43
0.87
-112.80
Leverage Ratio 10.20
ProfitabilityValueIndustryS&P 500US Markets
57.10
-139.10
-132.90
-212.90
-60.65
RevenueValueIndustryS&P 500US Markets
7.41M
0.59
3.67
-6.63
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.30-0.48-60.00
Q03 2020-0.40-0.52-30.00
Q02 2020-0.51-0.510.00
Q01 2020-0.60-0.4426.67
Q04 2019-0.60-0.600.00
Q03 2019-1.05-0.9014.29
Q02 2019--0.60-
Q01 2019-1.20-1.50-25.00
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.2425.00Positive
6/2021 QR-0.240.00-
12/2021 FY-0.961.03Positive
12/2022 FY-0.82-134.29Negative
Next Report Date29th Apr 2021
Estimated EPS Next Report-0.24
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume387.78K
Shares Outstanding12.60M
Trades Count2.87K
Dollar Volume3.34M
Avg. Volume471.12K
Avg. Weekly Volume1.49M
Avg. Monthly Volume510.47K
Avg. Quarterly Volume497.48K

Ekso Bionics Holdings Inc. (NASDAQ: EKSO) stock closed at 5.71 per share at the end of the most recent trading day (a -11.88% change compared to the prior day closing price) with a volume of 389.88K shares and market capitalization of 71.95M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 68 people. Ekso Bionics Holdings Inc. CEO is Jack Peurach.

The one-year performance of Ekso Bionics Holdings Inc. stock is 68.05%, while year-to-date (YTD) performance is -6.85%. EKSO stock has a five-year performance of -94.56%. Its 52-week range is between 2.8 and 14.98, which gives EKSO stock a 52-week price range ratio of 23.89%

Ekso Bionics Holdings Inc. currently has a PE ratio of -2.20, a price-to-book (PB) ratio of 16.94, a price-to-sale (PS) ratio of 11.96, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -71.19%, a ROC of -123.84% and a ROE of -267.45%. The company’s profit margin is -60.65%, its EBITDA margin is -132.90%, and its revenue ttm is $7.41 Million , which makes it $0.59 revenue per share.

Of the last four earnings reports from Ekso Bionics Holdings Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.24 for the next earnings report. Ekso Bionics Holdings Inc.’s next earnings report date is 29th Apr 2021.

The consensus rating of Wall Street analysts for Ekso Bionics Holdings Inc. is Strong Buy (1), with a target price of $10, which is +75.13% compared to the current price. The earnings rating for Ekso Bionics Holdings Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Ekso Bionics Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Ekso Bionics Holdings Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 19.28, ATR14 : 0.96, CCI20 : -98.63, Chaikin Money Flow : 0.08, MACD : -0.71, Money Flow Index : 77.01, ROC : -3.06, RSI : 38.04, STOCH (14,3) : 9.88, STOCH RSI : 0.34, UO : 49.40, Williams %R : -90.12), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Ekso Bionics Holdings Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets.

CEO: Jack Peurach

Telephone: +1 510 984-1761

Address: 1414 Harbour Way South, Richmond 94804, CA, US

Number of employees: 68

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

60%40%

Bearish Bullish

48%52%

Bearish Bullish

48%52%

News

Stocktwits